Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Immunity

• Publication date

  2010-06-25

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.immuni.2010.05.010PMID 20605485
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Autoimmune B-cell lymphopenia after successful adoptive therapy with telomerase-specific T lymphocytes.

  2010cited by this paper
• Hierarchy of immunosuppressive strength among myeloid‐derived suppressor cell subsets is determined by GM‐CSF

  2009influential reference
• Myeloid-derived suppressor cells as regulators of the immune system

  2009influential reference
• IL4Rα+ Myeloid-Derived Suppressor Cell Expansion in Cancer Patients1

  2009cited by this paper
• Toll-like receptor–induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens

  2008cited by this paper
• Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells.

  2008cited by this paper
• Subsets of Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice1

  2008cited by this paper
• Distinct Functions of CCAAT Enhancer-binding Protein Isoforms in the Regulation of Manganese Superoxide Dismutase during Interleukin-1β Stimulation*

  2008cited by this paper
• Preventive vaccination with telomerase controls tumor growth in genetically engineered and carcinogen-induced mouse models of cancer.

  2008cited by this paper
• Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein

  2008cited by this paper
• Tumor‐induced tolerance and immune suppression by myeloid derived suppressor cells

  2008influential reference
• Transcription factors in myeloid development: balancing differentiation with transformation

  2007cited by this paper
• Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer

  2007cited by this paper
• Altered macrophage differentiation and immune dysfunction in tumor development.

  2007influential reference
• C/EBPbeta is required for 'emergency' granulopoiesis.

  2006cited by this paper
• Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function

  2006cited by this paper
• p50 nuclear factor-kappaB overexpression in tumor-associated macrophages inhibits M1 inflammatory responses and antitumor resistance.

  2006cited by this paper
• Adoptive immunotherapy for cancer: building on success

  2006cited by this paper
• Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells.

  2006influential reference
• Boosting antitumor responses of T lymphocytes infiltrating human prostate cancers

  2005cited by this paper
• Induction of arginase I transcription by IL-4 requires a composite DNA response element for STAT6 and C/EBPbeta.

  2005cited by this paper
• Regulation of immune responses by L-arginine metabolism

  2005influential reference
• Prolongation of islet allograft survival following ex vivo transduction with adenovirus encoding a soluble type 1 TNF receptor–Ig fusion decoy

  2004cited by this paper
• High-Dose Granulocyte-Macrophage Colony-Stimulating Factor-Producing Vaccines Impair the Immune Response through the Recruitment of Myeloid Suppressor Cells

  2004cited by this paper
• Enhancer-Mediated Control of Macrophage-Specific Arginase I Expression1

  2004cited by this paper
• Flow cytometric study of neutrophilic granulopoiesis in normal bone marrow using an expanded panel of antibodies: Correlation with morphologic assessments

  2004cited by this paper
• C/EBP-β Mediates iNOS Induction by Hypoxia in Rat Pulmonary Microvascular Smooth Muscle Cells

  2002cited by this paper
• Myeloid Suppressor Lines Inhibit T Cell Responses by an NO-Dependent Mechanism1

  2002cited by this paper
• C/EBP-beta mediates iNOS induction by hypoxia in rat pulmonary microvascular smooth muscle cells.

  2002cited by this paper
• Characterization of C/EBPbeta isoforms in normal versus neoplastic mammary epithelial cells.

  2001cited by this paper
• Characterization of C/EBPβ isoforms in normal versus neoplastic mammary epithelial cells

  2001cited by this paper
• Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndrome.

  2001cited by this paper
• Autocrine Production of IL-10 Mediates Defective IL-12 Production and NF-κB Activation in Tumor-Associated Macrophages1

  2000cited by this paper
• Identification of a CD 11 b 1 / Gr-1 1 / CD 31 1 myeloid progenitor capable of activating or suppressing CD 8 1 T cells

  2000cited by this paper
• Identification of a CD11b(+)/Gr-1(+)/CD31(+) myeloid progenitor capable of activating or suppressing CD8(+) T cells.

  2000cited by this paper
• CCAAT/enhancer binding protein-β trans-activates murine nitric oxide synthase 2 gene in an MTAL cell line.

  1999cited by this paper
• Unopposed production of granulocyte-macrophage colony-stimulating factor by tumors inhibits CD8+ T cell responses by dysregulating antigen-presenting cell maturation.

  1999influential reference
• The Role of C/EBP Isoforms in the Control of Inflammatory and Native Immunity Functions*

  1998cited by this paper
• Van Damme A.

  1986cited by this paper

• Five-Year Clinical Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Unresectable Pleural Mesothelioma in CheckMate 743.

  2026cites this paper
• Myeloid-derived interleukin-10 induced by thrombospondin-1 mediates host defense and regulates inflammation during acute bacterial lung infection

  2026cites this paper
• Cannabidiol suppresses emergency MDSCs generation by disturbing EEF1B2-mediated C/EBPβ protein synthesis in colorectal adenomas

  2026cites this paper
• Innate lymphoid cells activated by the cytokine TL1A link colitis to emergency granulopoiesis and the recruitment of tumor-promoting neutrophils.

  2026cites this paper
• The stress and the alarmin-like cytokine interleukin-37 mediated extracellular and intracellular signal pathways.

  2025cites this paper
• Innate Immunity and Platelets: Unveiling Their Role in Chronic Pancreatitis and Pancreatic Cancer

  2025cites this paper
• ATP-NLRP3 inflammasome axis enhances the immunosuppressive effect of myeloid-derived suppressor cells.

  2025cites this paper
• Single-cell transcriptomic analysis identified resistant MDSCs and a stress-tolerant gene co-expression network as common MDSC features across multiple disease settings

  2025cites this paper
• A CEBPB/IL-1β/TNF-α Feedback Loop Drives Drug Resistance to Venetoclax and MDM2 Inhibitors in Monocytic Leukemia.

  2025cites this paper
• p38 blockade reverses the immune suppressive tumor microenvironment in metastatic breast cancer

  2025cites this paper
• Cell Carriers for Oncolytic Virus Delivery: Prospects for Systemic Administration

  2025cites this paper
• The Role of Protein Kinases in the Suppressive Phenotype of Myeloid-Derived Suppressor Cells

  2025cites this paper
• Potential functions of TRPM2 and TRPM7 channels in the tumor microenvironment.

  2025cites this paper
• Impact of post-transplant cyclophosphamide with bendamustine on immune reconstitution in young patients undergoing T-cell replete haploidentical bone marrow transplantation: results from a phase Ia/Ib clinical trial

  2025cites this paper
• Understanding and reversing mammary tumor-driven reprogramming of myelopoiesis to reduce metastatic spread

  2025cites this paper
• Delineation of monocytic and early‐stage myeloid‐derived suppressor cells in the peripheral blood of patients with hepatocarcinoma

  2025cites this paper
• Early Elevation of Monocytic-to-Polymorphonuclear Myeloid-Derived Suppressor Cells Ratio in Critical Illness is Associated with Favorable Clinical Outcomes

  2025cites this paper
• Myeloid cells: key players in tumor microenvironments

  2025cites this paper
• The Role of Tumor Microenvironment and Immune Cell Crosstalk in Triple-Negative Breast Cancer (TNBC): Emerging Therapeutic Opportunities.

  2025cites this paper
• p38 blockade reverses the immune suppressive tumor microenvironment in metastatic breast cancer

  2025cites this paper
• Bulk and Single‐Cell Transcriptomic Reveals Shared Key Genes and Patterns of Immune Dysregulation in Both Intestinal Inflammatory Disease and Sepsis

  2025cites this paper
• The acute myeloid leukemia microenvironment impairs neutrophil maturation and function through NF-κB signaling

  2025cites this paper
• RhIL-11 reverses liver damage in septic mice by STAT3-mediated M-MDSCs induction modulated by a parallel mTORC1 signaling branch

  2025influential citation
• Downregulated Smad3 signaling impairs the maturation of MO-MDSC in colorectal cancer

  2025cites this paper
• Myeloid-Derived Suppressor Cells: Implications in Cancer Immunology and Immunotherapy.

  2025cites this paper
• Induction of myelopoiesis by Candida dubliniensis drives protective trained immunity against sepsis in a Card9-dependent manner

  2025cites this paper
• Research trends and topics on sepsis immunosuppression: a bibliometric and visual analysis of global research from 2004 to 2024

  2025cites this paper
• EGR2 O-GlcNAcylation orchestrates the development of protumoral macrophages to limit CD8+ T cell antitumor responses.

  2025cites this paper
• Immune dysfunction during S. aureus biofilm-associated implant infections: opportunities for novel therapeutic strategies

  2025influential citation
• [Regulation of myeloid-derived suppressor cells by glutamate].

  2025cites this paper
• The impact of cytokines and tumour‐conditioned medium on the properties of murine in vitro generated myeloid‐derived suppressor cells

  2025cites this paper
• Epigenomic Heterogeneity of Non-Functional Pancreatic Neuroendocrine Tumors Uncovered by Single nucleus and Spatial ATAC Profiling

  2025cites this paper
• MDSC expansion during HIV infection: regulators, ART and immune reconstitution

  2024cites this paper
• Myeloid-derived suppressor cell mitochondrial fitness governs chemotherapeutic efficacy in hematologic malignancies

  2024cites this paper
• Splicing DNA Damage Adaptations for the Management of Cancer Cells.

  2024cites this paper
• mRNA cancer vaccines from bench to bedside: a new era in cancer immunotherapy

  2024cites this paper
• IL-37 dampens immunosuppressive functions of MDSCs via metabolic reprogramming in the tumor microenvironment.

  2024cites this paper
• Granulocyte-like myeloid-derived suppressor cells: The culprits of neutrophil extracellular traps formation in the pre-metastatic niche.

  2024cites this paper
• Engaging natural regulatory myeloid cells to restrict T-cell hyperactivation-induced liver inflammation via extracellular vesicle-mediated purine metabolism regulation

  2024cites this paper
• Research progress and challenges of the PD-1/PD-L1 axis in gliomas

  2024cites this paper
• Cholecystokinin and gastrin as immune modulating hormones: Implications and applications.

  2024cites this paper
• Emergency myelopoiesis in solid cancers

  2024cites this paper
• Single-cell profiling reveals a conserved role for hypoxia-inducible factor signaling during human craniotomy infection

  2024cites this paper
• Lupus-prone NZM2328 mice exhibit enhanced UV-induced myeloid cell recruitment and activation in a type I interferon dependent manner.

  2024cites this paper
• Unlocking the dual role of LSD1 in tumor immunity: innate and adaptive pathways

  2024cites this paper
• Tumor-derived GLI1 promotes remodeling of the immune tumor microenvironment in melanoma

  2024cites this paper
• Excess Potassium Promotes Autophagy to Maintain the Immunosuppressive Capacity of Myeloid-Derived Suppressor Cells Independent of Arginase 1

  2024cites this paper
• New insights on extramedullary granulopoiesis and neutrophil heterogeneity in the spleen and its importance in disease.

  2024cites this paper
• Myeloid-derived suppressor cells: Key immunosuppressive regulators and therapeutic targets in colorectal cancer (Review)

  2024cites this paper
• Nanomedicines modulate the tumor immune microenvironment for cancer therapy

  2024cites this paper
• Integrated multi-omics analysis and machine learning developed diagnostic markers and prognostic model based on Efferocytosis-associated signatures for septic cardiomyopathy.

  2024cites this paper
• Exportin 1 governs the immunosuppressive functions of myeloid-derived suppressor cells in tumors through ERK1/2 nuclear export

  2024cites this paper
• Tumor-associated NK cells drive MDSC-mediated tumor immune tolerance through the IL-6/STAT3 axis

  2024cites this paper
• Plasmodium yoelii Infection Enhances the Expansion of Myeloid-Derived Suppressor Cells via JAK/STAT3 Pathway.

  2024cites this paper
• Microenvironmental changes in familial adenomatous polyposis during colorectal cancer carcinogenesis.

  2024cites this paper
• Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumors

  2024cites this paper
• Dabrafenib Alters MDSC Differentiation and Function by Activation of GCN2

  2024cites this paper
• CaSSiDI: novel single-cell “Cluster Similarity Scoring and Distinction Index” reveals critical functions for PirB and context-dependent Cebpb repression

  2024cites this paper
• Made to order: emergency myelopoiesis and demand-adapted innate immune cell production

  2024cites this paper
• Bexarotene Induce Differentiation of Myeloid-Derived Suppressor Cells through Arg-1 Signalling Pathway.

  2024cites this paper
• Intracerebellar injection of monocytic immature myeloid cells prevents the adverse effects caused by stereotactic surgery in a model of cerebellar neurodegeneration

  2024cites this paper
• VISTA promotes the metabolism and differentiation of myeloid-derived suppressor cells by STAT3 and polyamine-dependent mechanisms

  2024cites this paper
• Myeloid-Derived Suppressor Cells Promote Allograft Survival By Suppressing Treg Dysfunction in High-Risk Corneal Transplantation.

  2024cites this paper
• Rg3-lipo biomimetic delivery of paclitaxel enhances targeting of tumors and myeloid-derived suppressor cells

  2024cites this paper
• Noncanonical TRAIL Signaling Promotes Myeloid-Derived Suppressor Cell Abundance and Tumor Growth in Cholangiocarcinoma

  2024cites this paper
• Infiltration of CD3+ and CD8+ lymphocytes in association with inflammation and survival in pancreatic cancer

  2024cites this paper
• IL-37d enhances COP1-mediated C/EBPβ degradation to suppress spontaneous neutrophil migration and tumor progression.

  2024cites this paper
• LC3-dependent extracellular vesicles promote M-MDSC accumulation and immunosuppression in colorectal cancer

  2024cites this paper
• FFAR2 expressing myeloid-derived suppressor cells drive cancer immunoevasion

  2024cites this paper
• Noncanonical TRAIL Signaling Facilitates Tumor Immunosuppression and Cholangiocarcinoma Growth via Myeloid-Derived Suppressor Cells

  2023cites this paper
• Neutrophils resist ferroptosis and promote breast cancer metastasis through aconitate decarboxylase 1.

  2023cites this paper
• Regulation of T cells by myeloid-derived suppressor cells: emerging immunosuppressor in lung cancer

  2023cites this paper
• Myeloid‐derived suppressor cells in the therapy of autoimmune diseases

  2023cites this paper
• Dabrafenib alters MDSC differentiation and function by activation of GCN2

  2023influential citation
• Specific Tumor Localization of Immunogenic Lipid-Coated Mesoporous Silica Nanoparticles following Intraperitoneal Administration in a Mouse Model of Serous Epithelial Ovarian Cancer

  2023cites this paper
• The Akt/mTOR and MNK/eIF4E pathways rewire the prostate cancer translatome to secrete HGF, SPP1 and BGN and recruit suppressive myeloid cells

  2023cites this paper
• Progress in research on the role played by myeloid‐derived suppressor cells in liver diseases

  2023cites this paper
• Activin A-Expressing Polymorphonuclear Myeloid-Derived Suppressor Cells Infiltrate Skeletal and Cardiac Muscle and Promote Cancer Cachexia.

  2023cites this paper
• Fully functional monocytic MDSC generation from the murine HoxB8 cell line

  2023cites this paper
• Noncanonical TRAIL Signaling Promotes Myeloid-Derived Suppressor Cell Abundance and Tumor Progression in Cholangiocarcinoma

  2023cites this paper
• Monocytic MDSCs exhibit superior immune suppression via adenosine and depletion of adenosine improves efficacy of immunotherapy

  2023cites this paper
• Tumor microenvironment interactions with cancer stem cells in pancreatic ductal adenocarcinoma.

  2023cites this paper
• Function of reactive oxygen species in myeloid-derived suppressor cells

  2023cites this paper
• Aldehyde dehydrogenase 2-mediated aldehyde metabolism promotes tumor immune evasion by regulating the NOD/VISTA axis

  2023cites this paper
• Mobilization of monocytic myeloid-derived suppressor cells is regulated by PTH1R activation in bone marrow stromal cells

  2023influential citation
• Transplantation immune responses: Biology, challenges, and opportunities using biomaterials

  2023cites this paper
• Tim-3 regulates the immunosuppressive function of decidual MDSCs via the Fyn-STAT3-C/EBPβ pathway during Toxoplasma gondii infection

  2023cites this paper
• Innate immune cellular therapeutics in transplantation

  2023influential citation
• Overcoming resistance to immunotherapy by targeting GPR84 in myeloid-derived suppressor cells

  2023cites this paper
• Immune checkpoint inhibitors and combinations with other agents in cholangiocarcinoma.

  2023cites this paper
• 5-Fluorouracil Suppresses Colon Tumor through Activating the p53-Fas Pathway to Sensitize Myeloid-Derived Suppressor Cells to FasL+ Cytotoxic T Lymphocyte Cytotoxicity

  2023cites this paper
• NAD+ biosynthesis metabolism predicts prognosis and indicates immune microenvironment for breast cancer

  2023cites this paper
• Apolipoprotein E induces pathogenic senescent-like myeloid cells in prostate cancer.

  2023cites this paper
• Bone serves as a transfer station for secondary dissemination of breast cancer

  2023cites this paper
• The role of myeloid derived suppressor cells in musculoskeletal disorders

  2023cites this paper
• Deciphering the roles of myeloid derived suppressor cells in viral oncogenesis

  2023cites this paper
• Metabolic reprogramming of myeloid-derived suppressor cells in the context of organ transplantation.

  2023cites this paper
• The role of myeloid-derived suppressor cells in liver cancer

  2023cites this paper
• JAK1/2 inhibitor ruxolitinib promotes the expansion and suppressive action of polymorphonuclear myeloid‐derived suppressor cells via the JAK/STAT and ROS‐MAPK/NF‐κB signalling pathways in acute graft‐versus‐host disease

  2023cites this paper
• "Open Sesame" to the complexity of pattern recognition receptors of myeloid-derived suppressor cells in cancer

  2023cites this paper